ALR Technologies Receives FDA Clearance For Breakthrough Diabetes Management System

ALR Technologies (ALRT)

ALR Technologies Inc., (OTCBB: ALRT) (the “Company”), a healthcare technology company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Health-e-Connect (HeC) System for remote monitoring of patients in support of effective diabetes management programs. The 510(k) clearance enables the Company to commence with the United States marketing and sales launch of its HeC platform.

Company CEO, Sidney Chan, commented, “We are pleased to reach this milestone and are eager to introduce to market this cross-platform technology. The HeC System represents a breakthrough for clinician/patient communication to enhance disease management and improve health outcomes. The System provides the potential to achieve significant savings to the US healthcare system through enhanced adherence to care plans. In anticipation of the FDA clearance, we have been cultivating relationships with manufacturers of diabetes test supplies and insurance companies to help facilitate a successful launch.”

President and COO Lawrence Weinstein added, “Diabetes management represents the initial chronic illness application for HeC and we plan to expand upon that platform in 2012. A first-to-market product, the HeC System bridges gaps in current remote monitoring systems in a manner that is efficient, effective and affordable. We anticipate a strong demand based upon our present relationships with industry leaders. Given the flexibility of the HeC System, the potential is enormous. This FDA clearance is a major stride in our commitment to building long-term shareholder value as there is a wide spectrum of chronic diseases which the HeC platform can be deployed to improve outcomes and contain costs.”

About ALR Technologies Inc.

The ALRT Health-e-Connect (HeC) System is the principal product of the Company. HeC is a web-based patient management platform for medical professionals to improve compliance and management of care plans of patients in their homes. HeC is currently programmed to assist healthcare providers caring for diabetes patients. The platform will be expanded to cover patients with other chronic diseases. More information on ALR Technologies and its products can be found at

This release contains certain “forward-looking statements” relating to ALR Technologies’ business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words “estimate,” “expect,” “anticipate,” “believe” and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the Company’s quarterly filings with the Securities Exchange Commission.

ALR Technologies (ALRT) Stock Quote and News:

Disclaimer: Neither nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has been compensated twenty thousand dollars per month for three months of consultation and journalism services and to manage a comprehensive investor relations/awareness program by ALR Technologies. Please read and fully understand our entire disclaimer at


Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

BioLargo Stock Chart Analysis Video(0)

A thin-floater, the BioLargo chart is climbing again as it has historically done off a bottom support at 20 cents. Technical traders will be watching for a 20 percent climb to take out resistance at 40 cents, which could free a path to the next resistance at 60 cents. BioLargo’s business strategy is to harness

Brightcove IPO Rings in at $11(0)

Falling right into the expected range of $10 - $12 a share, Brightcove, Inc.’s (NASDAQ:BCOV) initial public offering if for five million shares at $11 each. The yet-to-be-profitable provider of cloud-based internet video services had filed plans in August to raise up to approximately $50 million. Proceeds will be used for working capital and to

Wall Street Cruises Higher as Data Comforts Investors(0)

In New York, stocks moved solidly higher Thursday as positive domestic economic data comforted investors nervous about Greece’s ability to secure a second bailout. The Dow Jones Industrials gained 123.13 points, or 1% to end the session at 12,904.10 The S&P 500 gathered 14.67 points to 1,357.90, while the tech-focused Nasdaq accelerated 44.02 points to

Boeing Dreamliner Traces Logo in Sky During Test Flight(0)

This is good stuff.  Taking it a bit further than they did in August 2011 when they sketched “747” in the sky, Boeing Company (NYSE:BA) completed a 19-hour test flight of its 787 Dreamliner, doodling its way across the American skies.  Across thousands of miles between Iowa and Washington State, the numbers “787” and then

Shares of AER Energy Blast-Off on Acquisition News(0)

Shares of AER Energy Inc. (Pink Sheets:AERN) have been on a frantic upward pace in morning trading, after posting gains the two days prior, on fresh news that the company has successfully acquired three Oklahoma oil and gas leases from Fort Worth, Texas-based Texas Energy, Inc.  The purchase combines AER Petroleum, Inc and TX Energy’s

read more

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.